Evoxac



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Sjogren's Syndrome 52.2%
Dry Mouth 20.9%
Drug Use For Unknown Indication 7.5%
Product Used For Unknown Indication 7.5%
Atrial Fibrillation 3.0%
Neuropathy Peripheral 3.0%
Glaucoma 1.5%
Migraine 1.5%
Radiotherapy 1.5%
Rheumatoid Arthritis 1.5%
Vomiting 10.7%
Atrial Fibrillation 7.1%
Death 7.1%
Drug Ineffective 7.1%
Hallucination 7.1%
Road Traffic Accident 7.1%
Wheezing 7.1%
Anaphylactic Reaction 3.6%
Aphasia 3.6%
Arrhythmia 3.6%
Asthenia 3.6%
Atrioventricular Block 3.6%
Bradycardia 3.6%
Cardiac Operation 3.6%
Coeliac Disease 3.6%
Dyskinesia 3.6%
Economic Problem 3.6%
Electrocardiogram Abnormal 3.6%
Glaucoma 3.6%
Haemorrhagic Stroke 3.6%
Secondary
Rheumatoid Arthritis 28.9%
Arthralgia 8.9%
Depression 8.9%
Gastrointestinal Disorder Therapy 8.9%
Dry Mouth 6.7%
Product Used For Unknown Indication 6.7%
Blood Pressure 4.4%
Lymphadenitis 4.4%
Supplementation Therapy 4.4%
Anxiety 2.2%
Drug Use For Unknown Indication 2.2%
Dry Eye 2.2%
Dyspepsia 2.2%
Fibromyalgia 2.2%
Hypersensitivity 2.2%
Ill-defined Disorder 2.2%
Osteoporosis 2.2%
Localised Infection 25.0%
Lymphoma 25.0%
Somnolence 25.0%
Stomatitis 12.5%
Weight Increased 12.5%
Concomitant
Product Used For Unknown Indication 31.6%
Rheumatoid Arthritis 18.3%
Drug Use For Unknown Indication 6.7%
Sjogren's Syndrome 4.9%
Pain 4.5%
Osteoporosis 4.3%
Dry Mouth 4.2%
Hypertension 3.1%
Depression 2.6%
Dry Eye 2.5%
Gastrooesophageal Reflux Disease 2.5%
Vitamin Supplementation 2.1%
Migraine 2.0%
Systemic Lupus Erythematosus 1.9%
Asthma 1.7%
Hiv Infection 1.7%
Insomnia 1.5%
Pulmonary Arterial Hypertension 1.3%
Blood Cholesterol Increased 1.3%
Diabetes Mellitus 1.3%
Vomiting 11.0%
Weight Decreased 8.5%
Drug Ineffective 6.7%
Electrocardiogram Qt Prolonged 5.5%
Injection Site Pain 5.5%
Laryngospasm 5.5%
Transient Ischaemic Attack 5.5%
Urinary Tract Infection 5.5%
Wrist Fracture 5.5%
Death 4.9%
Pain In Extremity 4.9%
Pneumonia 3.7%
Suicidal Ideation 3.7%
Tongue Ulceration 3.7%
Urticaria 3.7%
Vitreous Haemorrhage 3.7%
Weight Increased 3.7%
Fatigue 3.0%
Palpitations 3.0%
Pharmaceutical Product Complaint 3.0%
Interacting
Hypertension 56.5%
Gastritis 8.7%
Insomnia 8.7%
Myocardial Ischaemia 8.7%
Pigmentation Disorder 8.7%
Sjogren's Syndrome 8.7%
Hypertension 100.0%